Trademarkia Logo

Australia

AU$
Trademark Search
ONCOLYTIC IMMUNOTHERAPY
ONCOLYTIC IMMUNOTHERAPY
Published: Under examination

Last updated on 30 Sept 2024

Owner Info

CG Oncology, Inc.

400 Spectrum Center Dr., Suite 2040

Irvine, California, 92618 UNITED STATES OF AMERICA,

Serial Number

2482273 filed on 12 Sept 2024

Correspondent

Ashurst Australia

GPO Box 9938,

SYDNEY, NSW, 2001 AUSTRALIA,

ONCOLYTIC IMMUNOTHERAPY

Classification Information


Class [005]
Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunolog Read More

Class [042]
Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immuno Read More

Mark Details


Serial Number

2482273

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

15 Mar 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
30th Sept 2024Adverse Report (Examination) correspondence sent
30th Sept 2024IP Right has been Examined
27th Sept 2024IP Right Amendment Made correspondence sent
27th Sept 2024IP right goods and service classes updated
27th Sept 2024IP Right Goods and Services Items updated
17th Sept 2024Awaiting examination
17th Sept 2024Examination expedited
13th Sept 2024IP Right Amendment Requested
12th Sept 2024IP Right Filed correspondence sent
12th Sept 2024IP Right Filed Published